Skip to main content
. 2017 Jun 29;12(6):e0179592. doi: 10.1371/journal.pone.0179592

Table 4. Patients reaching a low risk of disease progression (≤4 sites with PD≥5 mm) at 12 months.

Timepoints Group A ITT: n = 28 PP: n = 26 Group B ITT: n = 25 PP: n = 24 Group C ITT: n = 27 PP: n = 25 Groups A-B (Fisher-Test) Groups A-C (Fisher Test) Groups B-C (Fisher Test)
ITT analysis (n = 80) 6/21.4% 18/72.0% 13/48.1% <0.001s 0.049s 0.097
PP analysis (n = 75) 5/19.2% 17/70.8% 11/44.0 <0.001s 0.070 0.080

ITT: Intention to treat analyses, PP: per protocol analyses, PD: pocked depth, m: months